155 related articles for article (PubMed ID: 33257317)
1. Uveal melanoma-associated cancers revisited.
Alfaar AS; Saad A; Elzouki S; Abdel-Rahman MH; Strauss O; Rehak M
ESMO Open; 2020 Nov; 5(6):e000990. PubMed ID: 33257317
[TBL] [Abstract][Full Text] [Related]
2. Non-ocular primary malignancies in patients with uveal melanoma: the Liverpool experience.
Heussen FM; Coupland SE; Kalirai H; Damato BE; Heimann H
Br J Ophthalmol; 2016 Mar; 100(3):356-9. PubMed ID: 26178903
[TBL] [Abstract][Full Text] [Related]
3. Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma.
Abdel-Rahman MH; Pilarski R; Ezzat S; Sexton J; Davidorf FH
Fam Cancer; 2010 Sep; 9(3):431-8. PubMed ID: 20157784
[TBL] [Abstract][Full Text] [Related]
4. Uveal melanoma: a study on incidence of additional cancers in the Swedish population.
Bergman L; Nilsson B; Ragnarsson-Olding B; Seregard S
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):72-7. PubMed ID: 16384946
[TBL] [Abstract][Full Text] [Related]
5. Additional primary malignancies in a Polish cohort of uveal melanoma patients: a review of 644 patients with long-term follow-up.
Wróblewska-Zierhoffer M; Paprzycka B; Kubiak A; Tomczyk Ł; Rospond-Kubiak I
BMC Ophthalmol; 2023 Dec; 23(1):506. PubMed ID: 38087265
[TBL] [Abstract][Full Text] [Related]
6. The genetic basis of uveal melanoma.
Nielsen M; Dogrusöz M; Bleeker JC; Kroes WG; van Asperen CA; Marinkovic M; Luyten GP; Jager MJ
J Fr Ophtalmol; 2015 Jun; 38(6):516-21. PubMed ID: 25976137
[TBL] [Abstract][Full Text] [Related]
7. Uveal melanoma: A pathologist's perspective and review of translational developments.
Schoenfield L
Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
[TBL] [Abstract][Full Text] [Related]
8. Second Primary Neoplasms in Patients With Uveal Melanoma: A SEER Database Analysis.
Laíns I; Bartosch C; Mondim V; Healy B; Kim IK; Husain D; Miller JW
Am J Ophthalmol; 2016 May; 165():54-64. PubMed ID: 26940164
[TBL] [Abstract][Full Text] [Related]
9. The risk of other primary cancer in patients with uveal melanoma: a retrospective cohort study of a Canadian population.
Callejo SA; Al-Khalifa S; Ozdal PC; Edelstein C; Burnier MN
Can J Ophthalmol; 2004 Jun; 39(4):397-402. PubMed ID: 15327105
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of ocular and oculodermal melanocytosis in Spanish population with uveal melanoma.
Carreño E; Saornil MA; Garcia-Alvarez C; Lopez-Lara F; De Frutos-Baraja JM; Almaraz A
Eye (Lond); 2012 Jan; 26(1):159-62. PubMed ID: 22020174
[TBL] [Abstract][Full Text] [Related]
11. Other cancers in uveal melanoma patients and their families.
Turner BJ; Siatkowski RM; Augsburger JJ; Shields JA; Lustbader E; Mastrangelo MJ
Am J Ophthalmol; 1989 Jun; 107(6):601-8. PubMed ID: 2729409
[TBL] [Abstract][Full Text] [Related]
12. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
Spanogle JP; Clarke CA; Aroner S; Swetter SM
J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
[TBL] [Abstract][Full Text] [Related]
13. Unique Geospatial Accumulations of Uveal Melanoma.
Orloff M; Brennan M; Sato S; Shields CL; Shields JA; Lally S; Mashayekhi A; Mason J; Materin M; Mastrangelo M; Sato T
Am J Ophthalmol; 2020 Dec; 220():102-109. PubMed ID: 32681908
[TBL] [Abstract][Full Text] [Related]
14. Population-based incidence estimates of uveal melanoma in Germany. Supplementing cancer registry data by case-control data.
Stang A; Schmidt-Pokrzywniak A; Lehnert M; Parkin DM; Ferlay J; Bornfeld N; Marr A; Jöckel KH
Eur J Cancer Prev; 2006 Apr; 15(2):165-70. PubMed ID: 16523014
[TBL] [Abstract][Full Text] [Related]
15. Primary bilateral uveal melanoma: a population-based study and systematic review.
Scott JF; Vyas R; Galvin J; Gotow E; Fiessinger L; Gerstenblith AT; Gerstenblith MR
Clin Exp Ophthalmol; 2018 Jul; 46(5):502-510. PubMed ID: 29219254
[TBL] [Abstract][Full Text] [Related]
16. Iris Colour and the Risk of Developing Uveal Melanoma.
Houtzagers LE; Wierenga APA; Ruys AAM; Luyten GPM; Jager MJ
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998469
[TBL] [Abstract][Full Text] [Related]
17. Second Primary Malignancies in Patients With Melanoma Subtypes: Analysis of 120,299 Patients From the SEER Database (2000-2016).
Loya A; Gombos DS; Patel SP
Front Oncol; 2022; 12():853076. PubMed ID: 35372013
[TBL] [Abstract][Full Text] [Related]
18. Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the Surveillance, Epidemiology, and End Results database (1973-2012).
Mahendraraj K; Lau CS; Lee I; Chamberlain RS
Clin Ophthalmol; 2016; 10():2113-2119. PubMed ID: 27822007
[TBL] [Abstract][Full Text] [Related]
19. Second Primary Malignancies following a Diagnosis of Conjunctival Melanoma.
Mahjoub H; Loya A; Ayaz T; Weng CY
Curr Eye Res; 2022 Apr; 47(4):634-641. PubMed ID: 34898336
[TBL] [Abstract][Full Text] [Related]
20. Additional malignancies and mortality in uveal melanoma: A 20-year follow-up of a Norwegian patient cohort.
Robsahm TE; Falk RS; Eide NA
Acta Ophthalmol; 2023 Sep; 101(6):696-704. PubMed ID: 36924309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]